Sensor technology from Cambridge based company Camena Bioscience is being developed into a novel research instrument to improve the efficiency and cost of manufacturing medicines.
The production process needs to be carefully controlled to generate a consistent and high-quality product – image courtesy of Camena Bioscience. The £1.6m project to develop Camena Bioscience’s revolutionary small molecule detection technology is co-funded by Innovate UK. Camena, based at Chesterford Research Park as well as Pasadena (California, US), will…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
